Frontiers in Clinical Diabetes and Healthcare

Review

Accepted on 25 Mar 2025

Consumer-Oriented Review of Digital Diabetes Prevention Programs: Insights from the CDC's Diabetes Prevention Recognition Program

in Diabetes Therapies

Benjamin Lalani
Jalene Shim
Vidhu Vadini
Yllka Valdez
Daniel Zade
Nestoras Mathioudakis

Frontiers in Clinical Diabetes and Healthcare

doi 10.3389/fcdhc.2025.1562108

126 views

Original Research

Accepted on 24 Mar 2025

Design and methods of a multicenter randomized clinical trial of effects of diabetes-educated psychologist on glucose management and diabetes distress

in Diabetes Therapies

Johanna Zeijlemaker
Therese Anderbro
Sofia Sterner Isaksson
Marcus Lind

Frontiers in Clinical Diabetes and Healthcare

doi 10.3389/fcdhc.2025.1549234

106 views

Original Research

Published on 24 Mar 2025

Exploring factors predicting the effectiveness of oral semaglutide in Japanese individuals with type 2 diabetes switching from dipeptidyl peptidase 4 inhibitors: a pilot study

in Diabetes Therapies

Takao Hirotsu
Kanta Taniguchi
Rimei Nishimura

Frontiers in Clinical Diabetes and Healthcare

doi 10.3389/fcdhc.2025.1520389

270 views

Opinion

Published on 09 Jan 2025

GLP-1 receptor agonists in diabetes and weight loss: the double-edged sword of innovation and risks

in Diabetes Therapies

Ioannis Ilias
Lina Zabuliene
Manfredi Rizzo

Frontiers in Clinical Diabetes and Healthcare

doi 10.3389/fcdhc.2024.1530811

1,546 views

Case Report

Published on 19 Dec 2024

Inhibition of leukotrienes and their potential role in type 1 diabetes pathogenesis: implications for montelukast as a therapeutic agent: a case report

in Diabetes Therapies

Pavel Fatulla
Ingela Ström
Christine Lingblom
Marcus Lind

Frontiers in Clinical Diabetes and Healthcare

doi 10.3389/fcdhc.2024.1494470

901 views

Editorial

Published on 22 Apr 2024

Editorial: Diabetes, transplantation and regenerative medicine

in Diabetes Therapies

Alessandro Mattina
David Baidal
Braulio Marfil-Garza
Margherita Occhipinti
Valeria Sordi

Frontiers in Clinical Diabetes and Healthcare

doi 10.3389/fcdhc.2024.1388904

1,395 views

Original Research

Published on 19 Apr 2024

Effect of metformin adjunct therapy on cardiometabolic parameters in Indian adolescents with type 1 diabetes: a randomized controlled trial

in Diabetes Therapies

Shruti Mondkar
Sukeshini Khandagale
Nikhil Shah
Anuradha Khadilkar
Chirantap Oza
Shital Bhor
Ketan Gondhalekar
Aneeta Wagle
Neha Kajale
Vaman Khadilkar

Frontiers in Clinical Diabetes and Healthcare

doi 10.3389/fcdhc.2024.1353279

1,734 views

Original Research

Published on 13 Nov 2023

Impact of GAD65 and IA2 autoantibodies on islet allograft survival

in Diabetes Therapies

Joana R. N. Lemos
Raffaella Poggioli
Jonathan Ambut
Nujen C. Bozkurt
Ana M. Alvarez
Nathalia Padilla
Francesco Vendrame
Camillo Ricordi
David A. Baidal
Rodolfo Alejandro

Frontiers in Clinical Diabetes and Healthcare

doi 10.3389/fcdhc.2023.1269758

1,888 views
1 citation

Original Research

Published on 31 Aug 2023

Incidence and predictors of mortality in children with diabetic ketoacidosis in the comprehensive specialized referral hospitals of West Amhara Region, Northwest Ethiopia: a retrospective follow-up study

in Diabetes Therapies

Rahel Asres Shimelash
Getaneh Mulualem Belay
Worknesh Aknaw
Aster Tadesse Shibabaw
Aderajew Agmas Adebabay
Gezahagn Demsu Gedefaw
Tadele Derbew Kassie
Alemu Birara Zemariam

Frontiers in Clinical Diabetes and Healthcare

doi 10.3389/fcdhc.2023.1204133

3,211 views
2 citations

Original Research

Published on 30 May 2023

The clinical implications of fasting serum insulin levels in patients with insulin-treated type 2 diabetes: a cross-sectional survey

in Diabetes Therapies

Lingli Zhou
Yingying Luo
Yan Wang
Yao Cheng
Rui Zhang
Simin Zhang
Siqian Gong
Xueyao Han
Linong Ji

Frontiers in Clinical Diabetes and Healthcare

doi 10.3389/fcdhc.2023.1172208

3,317 views

Review

Published on 09 Mar 2023

Dopamine receptor agonists mechanism of actions on glucose lowering and their connections with prolactin actions

in Diabetes Therapies

Hung-Yu Chien
Su-Mei Chen
Wan-Chun Li

Frontiers in Clinical Diabetes and Healthcare

doi 10.3389/fcdhc.2023.935872

7,760 views
11 citations

Original Research

Published on 03 Oct 2022

Aspalathin-rich green rooibos tea in combination with glyburide and atorvastatin enhances lipid metabolism in a db/db mouse model

in Diabetes Therapies

Oelfah Patel
Christo J. F. Muller
Elizabeth Joubert
Bernd Rosenkranz
Johan Louw
Charles Awortwe

Frontiers in Clinical Diabetes and Healthcare

doi 10.3389/fcdhc.2022.963489

3,606 views
2 citations

Original Research

Published on 26 Jul 2022

Intensification of Insulin Treatment With Insulin Degludec/Aspart in Type 2 Diabetic Patients: A 2-Year Real-World Experience

in Diabetes Therapies

Hatice Oner
Hatice Gizem Gunhan
Dilek Gogas Yavuz

Frontiers in Clinical Diabetes and Healthcare

doi 10.3389/fcdhc.2022.783277

2,090 views
1 citation

Original Research

Published on 05 Jul 2022

A Changed Gut Microbiota Diversity Is Associated With Metabolic Improvements After Duodenal Mucosal Resurfacing With Glucagon-Like-Peptide-1 Receptor Agonist in Type 2 Diabetes in a Pilot Study

in Diabetes Therapies

Suzanne Meiring
Annieke C. G. van Baar
Nikolaj Sørensen
Frits Holleman
Maarten R. Soeters
Max Nieuwdorp
Jacques J. G. H. M. Bergman

Frontiers in Clinical Diabetes and Healthcare

doi 10.3389/fcdhc.2022.856661

3,289 views
8 citations

Original Research

Published on 12 Oct 2021

Dapagliflozin, as Add-on Therapy in Type 2 Diabetes Patients, Is Associated With a Reduction in Albuminuria and Serum Transaminase Levels

in Diabetes Therapies

Silas Benjamin
Manjunath Ramanjaneya
Alexandra E. Butler
Imran Janjua
Firjeeth Paramba
Jafer Palaki
Aisha Al Kubaisi
Prem Chandra
Ibrahem Abdalhakam
Nasseer Ahmad Massodi

Frontiers in Clinical Diabetes and Healthcare

doi 10.3389/fcdhc.2021.733693

1,881 views
1 citation